-
公开(公告)号:US20150150798A1
公开(公告)日:2015-06-04
申请号:US14571883
申请日:2014-12-16
申请人: Ferring B.V.
IPC分类号: A61K9/00 , A61K47/36 , A61K47/10 , A61K31/4545 , B65D75/36 , A61K31/47 , A61K31/4178 , A61K47/26 , A61K47/12 , A61J1/03 , A61K38/22 , A61K31/426
CPC分类号: B65B31/04 , A61J1/035 , A61K9/0002 , A61K9/0056 , A61K9/205 , A61K9/2095 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K38/11 , A61K38/22 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , B65B3/04 , B65B63/08 , B65D75/367
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
摘要翻译: 本发明涉及包含携带药物活性成分的开放性基质网络的药物组合物,其中所述开放性基质网络包含levan。
-
公开(公告)号:US20180297728A1
公开(公告)日:2018-10-18
申请号:US16010412
申请日:2018-06-16
申请人: Ferring B.V.
IPC分类号: B65B31/04 , B65B3/04 , A61K9/20 , B65D75/36 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , A61J1/03 , A61K38/22 , A61K9/00 , B65B63/08 , A61K38/11 , A61K31/47 , A61K31/4545 , A61K31/426 , A61K31/4178
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
-
公开(公告)号:US10512695B2
公开(公告)日:2019-12-24
申请号:US16115650
申请日:2018-08-29
申请人: Ferring B.V.
IPC分类号: A61K47/36 , A61K38/095 , A61K9/00 , A61K9/19 , A61K31/426 , A61K31/4545 , A61K31/47 , C07K7/50
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises inulin.
-
公开(公告)号:US10023335B2
公开(公告)日:2018-07-17
申请号:US14571883
申请日:2014-12-16
申请人: Ferring B.V.
IPC分类号: A61K9/00 , B65B31/04 , A61K9/20 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K38/11 , B65B3/04 , B65B63/08 , A61J1/03 , A61K38/22 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , B65D75/36
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
-
公开(公告)号:US09096335B2
公开(公告)日:2015-08-04
申请号:US13952084
申请日:2013-07-26
申请人: Ferring B.V.
IPC分类号: A61K9/00 , B65B63/08 , B65B31/04 , A61K9/20 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K38/11 , B65B3/04
CPC分类号: B65B31/04 , A61J1/035 , A61K9/0002 , A61K9/0056 , A61K9/205 , A61K9/2095 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K38/11 , A61K38/22 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , B65B3/04 , B65B63/08 , B65D75/367
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
摘要翻译: 本发明涉及包含携带药物活性成分的开放性基质网络的药物组合物,其中所述开放性基质网络包含levan。
-
公开(公告)号:US10952959B2
公开(公告)日:2021-03-23
申请号:US16477127
申请日:2018-01-11
申请人: Ferring B.V.
发明人: Ganeshchandra Sonavane , Daniel Plaksin , Varinder Ahuja , Parag Lokhande , Devendra Kantilal Jain
IPC分类号: A61K9/00 , A61K38/095 , A61K9/19 , A61K9/20 , A61K31/404 , A61K31/47 , A61K31/4985 , A61K31/519
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network incorporating one or more pharmaceutically active ingredients, wherein the open matrix network comprises maltodextrin and hyaluronic acid or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20170304456A1
公开(公告)日:2017-10-26
申请号:US15644933
申请日:2017-07-10
申请人: Ferring B.V.
IPC分类号: A61K47/36 , A61K47/26 , A61K9/00 , A61K9/19 , A61K31/426 , A61K31/4178 , C07K5/12 , A61K31/47 , A61K31/4545 , A61K31/4155 , A61K38/11 , A61K31/733 , C07K7/00 , C07K7/16 , C07K7/06
CPC分类号: A61K47/36 , A23V2250/5046 , A23V2250/5062 , A23V2250/5068 , A61K9/0056 , A61K9/19 , A61K31/4155 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K31/733 , A61K38/095 , A61K47/26 , C07K5/12 , C07K7/00 , C07K7/06 , C07K7/16 , Y02A50/411
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises both the polysaccharides levan and inulin.
-
公开(公告)号:US20130310319A1
公开(公告)日:2013-11-21
申请号:US13952084
申请日:2013-07-26
申请人: Ferring B.V.
CPC分类号: B65B31/04 , A61J1/035 , A61K9/0002 , A61K9/0056 , A61K9/205 , A61K9/2095 , A61K31/4178 , A61K31/426 , A61K31/4545 , A61K31/47 , A61K38/11 , A61K38/22 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/36 , B65B3/04 , B65B63/08 , B65D75/367
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.
-
公开(公告)号:US20180369392A1
公开(公告)日:2018-12-27
申请号:US16115650
申请日:2018-08-29
申请人: Ferring B.V.
IPC分类号: A61K47/36 , A61K31/4545 , A61K9/00 , A61K38/11 , A61K31/47 , A61K31/426 , A61K9/19 , C07K7/50
摘要: The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises inulin.
-
公开(公告)号:US20150306170A1
公开(公告)日:2015-10-29
申请号:US14443759
申请日:2013-11-21
申请人: FERRING B.V.
发明人: Varinder Ahuja , Rajan Verma , Umesh Vinayakrao Barabde , Arne Hagsten , Kristin Wannerberger , Rambabu Boorugu , Amol Vilasrao Somwanshi
IPC分类号: A61K38/11 , A61K9/00 , A61K9/16 , A61K31/137
CPC分类号: A61K38/095 , A61K9/0056 , A61K9/2081 , A61K9/2095 , A61K9/5078 , A61K31/137
摘要: The subject invention relates to fast dissolving pharmaceutical compositions comprising an active ingredient for immediate release and further comprising a controlled release dosage form comprising an active ingredient for controlled release.
摘要翻译: 本发明涉及包含用于立即释放的活性成分的快速溶解药物组合物,并且还包含包含用于控制释放的活性成分的控释剂型。
-
-
-
-
-
-
-
-
-